Cardurion Pharmaceuticals, Inc.
Clinical trials sponsored by Cardurion Pharmaceuticals, Inc., explained in plain language.
-
New heart failure drug shows promise in latest trial
Disease control CompletedThis study tested a new drug called tovinontrine in 303 adults with chronic heart failure (a condition where the heart doesn't pump as well as it should). The goal was to see if the drug could lower a key marker of heart strain (NT-proBNP) compared to a placebo. The trial has com…
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 05:23 UTC
-
New heart failure drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called tovinontrine in 557 adults with chronic heart failure and reduced pumping ability. The goal was to see if it safely lowers a key heart stress marker (NT-proBNP) compared to a placebo. Participants took the drug or placebo for 12 weeks, and …
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC